JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
Sea Limited
SE
$65.4B
| $3.14M | ﹤0.01% |
54,100
+16,000
| +42% | +$1.14M |
|
3077
Empire State Realty Trust
ESRT
$872M
| $3.13M | ﹤0.01% |
417,979
+47,728
| +13% | +$301K |
|
3078
Ameresco
AMRC
$1.12B
| $3.13M | ﹤0.01% |
64,328
+2,266
| +4% | +$102K |
|
3079
IonQ
IONQ
$13.6B
| $3.13M | ﹤0.01% |
231,063
+59,809
| +35% | +$497K |
|
3080
Zentalis Pharmaceuticals
ZNTL
$337M
| $3.12M | ﹤0.01% |
110,693
+50,092
| +83% | +$1.2M |
|
3081
Lightspeed Commerce
LSPD
$1.31B
| $3.12M | ﹤0.01% |
184,204
-15,529
| -8% | -$223K |
|
3082
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.62B
| $3.11M | ﹤0.01% |
33,288
| – | – |
|
3083
WisdomTree US High Dividend Fund
DHS
$1.56B
| $3.11M | ﹤0.01% |
39,060
+9,559
| +32% | +$765K |
|
|
DOCU
3084
PUT
DocuSign
DOCU
$10.5B
| $3.11M | ﹤0.01% |
60,800
-804,000
| -93% | -$42.6M |
|
3085
Myriad Genetics
MYGN
$270M
| $3.1M | ﹤0.01% |
133,678
-24,184
| -15% | -$528K |
|
|
OPTU
3086
Optimum Communications Inc
OPTU
$298M
| $3.1M | ﹤0.01% |
1,025,443
+484,874
| +90% | +$1.38M |
|
3087
Turning Point Brands
TPB
$1.45B
| $3.09M | ﹤0.01% |
128,876
-127,059
| -50% | -$2.86M |
|
3088
Green Brick Partners
GRBK
$3.04B
| $3.09M | ﹤0.01% |
54,334
+19,517
| +56% | +$908K |
|
3089
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $3.08M | ﹤0.01% |
88,611
-16,266
| -16% | -$539K |
|
3090
PSQ Holdings
PSQH
$13.9M
| $3.08M | ﹤0.01% |
20,000
+6,667
| +50% | +$1.02M |
|
3091
PUT
Regions Financial
RF
$26.4B
| $3.08M | ﹤0.01% |
172,600
+9,000
| +6% | +$159K |
|
3092
Biomea Fusion
BMEA
$84.6M
| $3.08M | ﹤0.01% |
140,099
-24,800
| -15% | -$776K |
|
3093
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.71B
| $3.07M | ﹤0.01% |
34,663
+6,028
| +21% | +$508K |
|
|
ARIS
3094
DELISTED
Aris Water Solutions
ARIS
| $3.07M | ﹤0.01% |
297,239
+9,716
| +3% | +$84K |
|
3095
AbCellera Biologics
ABCL
$1.74B
| $3.07M | ﹤0.01% |
474,731
-236,555
| -33% | -$1.61M |
|
3096
Vicor
VICR
$9.56B
| $3.07M | ﹤0.01% |
56,782
-7,832
| -12% | -$386K |
|
3097
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$16.7B
| $3.06M | ﹤0.01% |
123,298
-198,389
| -62% | -$3.66M |
|
|
CIR
3098
DELISTED
CIRCOR International, Inc
CIR
| $3.06M | ﹤0.01% |
54,232
+37,434
| +223% | +$1.31M |
|
3099
Cerence
CRNC
$385M
| $3.06M | ﹤0.01% |
104,679
-27,225
| -21% | -$746K |
|
3100
Xenon Pharmaceuticals
XENE
$6.06B
| $3.05M | ﹤0.01% |
79,217
+46,430
| +142% | +$1.85M |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.